We are delighted to introduce you to our new RSC Pharmaceutics Editorial Board member, Professor Jessica Larsen.
Professor Larsen is the Carol and John ’63 Cromer Family Endowed Associate Professor, currently holding position at Clemson University.
She began her academic career at the University of Virginia, obtaining her BS in Chemical Engineering in 2012. She obtained her PhD in Chemical Engineering from Auburn University, where she was able to perform research under Drs. Mark Byrne in Chemical Engineering and Doug Martin in the College of Veterinary Medicine. Her research focuses on polymer-based nanotechnology to enable the treatment of neurologic conditions, delivering drugs across the blood-brain and blood-nerve barriers. In her undergraduate mentoring efforts, she has received the Phil and Mary Bradley Award for Mentoring in Creative Inquiry in 2020. She was also selected as the 2021 Outstanding Faculty Woman at Clemson University. She received the NSF CAREER Award in the Spring of 2021, the Governor’s Young Scientist Award for Excellence in Scientific Research in 2022, and the College of Engineering, Computing and Applied Science Junior Researcher of the Year in 2024. She has been an invited speaker at the Controlled Release Society Annual Meeting, the American Institute of Chemical Engineers Annual Meeting, and the World Biomaterials Congress. Her work has been continually funded by the NSF, NIH, and multiple disease-specific foundations since her lab’s inception in 2017.
Read some of Professor Larsen’s research:
Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges
Chloe Forenzo, Jessica Larsen
Mol. Pharmaceutics 2023, 20, 9, 4387–4403
Combining Nanoparticle Shape Modulation and Polymersome Technology in Drug Delivery
Cara Katterman, Christopher Pierce, Jessica Larsen
ACS Appl. Bio Mater. 2021, 4, 4, 2853–2862
The characterization of self-assembled nanostructures in whole blood
Mark Pitman and Jessica Larsen
Anal. Methods, 2020, 12, 2068-2081
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn or BlueSky. You can also keep informed by signing up to our E-Alerts.